Bangkok Genomics Innovation PCL (BKK:BKGI) Total Payout Ratio : -27.00 (As of Jun. 11, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Bangkok Genomics Innovation PCL Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Bangkok Genomics Innovation PCL's current Total Payout Ratio is -27.00.

Bangkok Genomics Innovation PCL Total Payout Ratio Historical Data

The historical data trend for Bangkok Genomics Innovation PCL's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Genomics Innovation PCL Total Payout Ratio Chart

Bangkok Genomics Innovation PCL Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Payout Ratio

0.13

-0.31

1.37

Bangkok Genomics Innovation PCL Quarterly Data
	Dec20	Dec21	Mar22	Dec22	Mar23	Dec23	Mar24
Total Payout Ratio	Get a 7-Day Free Trial			-	-	1.28	-	-27.00

Competitive Comparison of Bangkok Genomics Innovation PCL's Total Payout Ratio

For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bangkok Genomics Innovation PCL's Total Payout Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Bangkok Genomics Innovation PCL's Total Payout Ratio falls into.

Bangkok Genomics Innovation PCL Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Bangkok Genomics Innovation PCL's Total Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	-44)	/	32.142
	=	1.37

Bangkok Genomics Innovation PCL's Total Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	260.8	+	0)	/	9.66
	=	-27.00

Bangkok Genomics Innovation PCL Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Bangkok Genomics Innovation PCL's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Bangkok Genomics Innovation PCL (BKK:BKGI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bangkok Genomics Innovation PCL (BKK:BKGI) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110

Website

https://www.bangkokgenomics.com

Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products).